Clinical Trial Update: Efficacy and Safety Evaluation of Pneumostem® Versus a Control Group for Treatment of BPD in Premature Infants [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating Pneumostem® vs control for bronchopulmonary dysplasia in premature infants, focusing on efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia

Drugs mentioned

• PNEUMOSTEM

Snippet

Sponsor: Medipost Co Ltd. | Conditions: Bronchopulmonary Dysplasia | Phase 2 | Status: COMPLETED